4-Nitroquinoline N-oxide
(Synonyms: 4-硝基喹啉-N-氧化物) 目录号 : GC13127
4-Nitroquinoline N-oxide是一种强致突变性和致癌性化合物，能够诱导DNA损伤和氧化应激而成为癌症研究和DNA修复机制研究中的重要工具。
Cas No.:56-57-5
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
4-Nitroquinoline N-oxide is a potent mutagenic and carcinogenic compound that induces DNA damage and oxidative stress, making 4-Nitroquinoline N-oxide an important tool for cancer research and the study of DNA repair mechanisms[1]. 4-Nitroquinoline N-oxide is commonly used to induce cancers such as oral and esophageal cancer in animal models to study tumor development mechanisms and the efficacy of potential cancer therapies[2-3]. 4-Nitroquinoline N-oxide intercalates into DNA, causing oxidative damage and inducing the formation of DNA adducts, which lead to mutations and cancer development[4].
In vitro, treatment of the epidermoid carcinoma cell line KB with 4-Nitroquinoline N-oxide (0.5, 1.0, 2.0µM) significantly induced apoptosis and arrested the cell cycle in the G1 phase. 4-Nitroquinoline N-oxide can cause mitochondrial damage, leading to upregulation of Bax expression and downregulation of Bcl-2[5]. Jurkat T cells and Daudi B cells were treated with 4-Nitroquinoline N-oxide (0.5, 1, 1.5, 2mM) for 48 hours, 4-Nitroquinoline N-oxide significantly reduced the viability of Daudi B cells, increased the expression of the γH2AX protein, induced DNA damage, and promoted apoptosis. However, 4-Nitroquinoline N-oxide had less toxicity towards Jurkat T cells[6].
In vivo, 4-Nitroquinoline N-oxide (100µg/ml) was administered to C57BL/6J mice through drinking water for 8 and 16 weeks to induce esophageal squamous cell carcinoma (ESCC). Mice treated with 4-Nitroquinoline N-oxide for 8 weeks exhibited esophageal epithelial dysplasia, while those treated for 16 weeks developed esophageal cancer. The esophageal lesions induced by 4-Nitroquinoline N-oxide progressed from hyperplasia to dysplasia and eventually to carcinoma[7]. 4-Nitroquinoline N-oxide (100µg/ml) was given to C57BL/6J mice through drinking water for 16 weeks. Senescent cells in the esophagus were detected by bioluminescence imaging in p16+/LUC mice at 14 weeks, primarily in the non-side population (Non-SP) cells. These senescent cells showed significant upregulation of Oncostatin-M (OSM), a cytokine associated with cancer development that can activate oncogenes such as C-MYC. Additionally, the migration of marrow-derived Gfp+ cells into the esophagus was detected in mice treated with 4-Nitroquinoline N-oxide[8].
References:
[1] Bouaoud J, De Souza G, Darido C, et al. The 4-NQO mouse model: An update on a well-established in vivo model of oral carcinogenesis. Methods Cell Biol. 2021;163:197-229.
[2] Li W, Zeng Q, Wang B, et al. Oxidative stress promotes oral carcinogenesis via Thbs1-mediated M1-like tumor-associated macrophages polarization. Redox Biol. 2024 Oct;76:103335.
[3] Sui X, Chen C, Zhou X, et al. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2023 Feb 27;42(1):51.
[4] Grawish ME, Zyada MM, Zaher AR. Inhibition of 4-NQO-induced F433 rat tongue carcinogenesis by oleuropein-rich extract. Med Oncol. 2011 Dec;28(4):1163-8.
[5] Han H, Pan Q, Zhang B, et al. 4-NQO induces apoptosis via p53-dependent mitochondrial signaling pathway. Toxicology. 2007 Feb 12;230(2-3):151-63.
[6] Sahu SR, Thakur S, Peroumal D, et al. 4-nitroquinoline 1-oxide induces immune cells death to onset early immunosuppression during oral squamous cell carcinoma development. Front Immunol. 2023 Oct 23;14:1274519.
[7] Aziz Z, Washington MK, Jacobse J, et al. A method for scoring 4-nitroquinoline 1-oxide-induced murine esophageal squamous neoplasia. Vet Pathol. 2023 May;60(3):384-393.
[8] Mukherjee A, Epperly MW, Fisher R, et al. Carcinogen 4-Nitroquinoline Oxide (4-NQO) Induces Oncostatin-M (OSM) in Esophageal Cells. In Vivo. 2023 Mar-Apr;37(2):506-518.
4-Nitroquinoline N-oxide是一种强致突变性和致癌性化合物，能够诱导DNA损伤和氧化应激而成为癌症研究和DNA修复机制研究中的重要工具[1]。4-Nitroquinoline N-oxide常用于诱导动物模型中的口腔癌、食管癌等癌症，以研究肿瘤发生机制和潜在癌症治疗的疗效[2-3]。4-Nitroquinoline N-oxide通过嵌入 DNA，引起氧化损伤并诱导 DNA 加合物的形成，从而导致突变和癌症的发生[4]。
在体外，4-Nitroquinoline N-oxide（0.5、1.0、2.0μM）处理表皮样癌细胞系（KB），4-Nitroquinoline N-oxide显著诱导细胞凋亡，并将细胞周期停滞在G（1）期。4-Nitroquinoline N-oxide可对线粒体造成损伤，引起bax表达水平上调和bcl-2下调[5]。4-Nitroquinoline N-oxide（0.5, 1, 1.5, 2mM）处理Jurkat T细胞和Daudi B细胞48小时，4-Nitroquinoline N-oxide显著抑制Daudi B细胞的活性，同时引起细胞中γH2AX蛋白表达水平，诱导DNA损伤，引起细胞凋亡水平增加，但4-Nitroquinoline N-oxide对Jurkat T细胞的毒性较小[6]。
在体内，4-Nitroquinoline N-oxide（100µg/ml）通过饮水给予C57BL/6J小鼠，分别处理8周和16周，用于诱导食管鳞状细胞癌（ESCC）。4-Nitroquinoline N-oxide处理8周的小鼠主要表现为食管上皮的异型增生，而处理16周的小鼠则发展为食管癌。4-Nitroquinoline N-oxide诱导的食管病变从增生进展到异型增生，最终发展为癌[7]。4-Nitroquinoline N-oxide以100µg/ml的浓度通过饮水给予C57BL/6J小鼠，持续16周。4-Nitroquinoline N-oxide处理的小鼠在14周时通过p16+/LUC小鼠的荧光素酶成像检测到食管中的衰老细胞，这些细胞主要位于非侧群（Non-SP）细胞中。4-NQO诱导的衰老细胞表现出Oncostatin-M（OSM）的显著上调，OSM是一种与癌症发生相关的细胞因子，能够激活C-MYC等癌基因。4-Nitroquinoline N-oxide处理的小鼠食管中还检测到骨髓来源的Gfp+细胞的迁移[8]。
| Cell experiment [1]: | |
Cell lines | Jurkat T cells and Daudi B cells |
Preparation Method | Jurkat T cells and Daudi B cells were seeded into 48-well plates at a density of 1 × 10⁵ cells per well and cultured in RPMI-1640 medium containing 10% fetal bovine serum, 2mM glutamine, and 100U/ml penicillin and 100mg/ml streptomycin for 24 hours. The cells were then treated with different concentrations (0, 0.5, 1, 1.5, 2mM) of 4-Nitroquinoline N-oxide for 48 hours. |
Reaction Conditions | 0.5, 1, 1.5, 2mM 4-Nitroquinoline N-oxide; 48 hours |
Applications | 4-Nitroquinoline N-oxide significantly reduced the viability of Daudi B cells compared to Jurkat T cells, indicating higher susceptibility of B cells to 4-Nitroquinoline N-oxide. 4-Nitroquinoline N-oxide also induced DNA damage, marked by increased γH2AX expression, and promoted apoptosis in Daudi B cells. |
| Animal experiment [2]: | |
Animal models | C57BL/6J mice |
Preparation Method | Male C57BL/6J mice were used. Mice were given 4-Nitroquinoline N-oxide at a concentration of 100µg/ml in their drinking water continuously for 16 weeks. Control mice were given regular drinking water without 4-Nitroquinoline N-oxide. At 14 weeks, senescent cells in the esophagus were detected using p16+/LUC mice through bioluminescence imaging. Other tdTOMp16+ mice treated with 4-Nitroquinoline N-oxide for the same duration were sacrificed, and their esophagi were removed for sorting of side population (SP) cells and non-side population (Non-SP) cells to analyze senescent cells and gene expression. At the end of the experiment, the esophagi were examined for histological changes and gene expression levels. |
Dosage form | 100µg/ml in drinking water for 16 weeks |
Applications | 4-Nitroquinoline N-oxide significantly increased the number of senescent cells in the esophagus, particularly in the Non-SP cell population. These senescent cells showed upregulation of Oncostatin-M (OSM), a cytokine associated with cancer development. Additionally, 4-Nitroquinoline N-oxide treatment led to the migration of marrow-derived Gfp+ cells into the esophagus, indicating an inflammatory response. |
References: | |
| Cas No. | 56-57-5 | SDF | |
| 别名 | 4-硝基喹啉-N-氧化物 | ||
| 化学名 | 4-nitroquinoline 1-oxide | ||
| Canonical SMILES | [O-][N+](=O)c1cc[n+]([O-])c2ccccc12 | ||
| 分子式 | C9H6N2O3 | GC40165分子量 | 190.16 |
| 溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 5.2587 mL | 26.2936 mL | 52.5873 mL |
| 5 mM | 1.0517 mL | 5.2587 mL | 10.5175 mL |
| 10 mM | 0.5259 mL | 2.6294 mL | 5.2587 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet